- Short Report
- Open Access
Androgen receptor signalling in Vascular Endothelial cells is dispensable for spermatogenesis and male fertility
BMC Research Notesvolume 5, Article number: 16 (2012)
Androgen signalling is essential both for male development and function of the male reproductive system in adulthood. Within the adult testis, Germ cells (GC) do not express androgen receptor (AR) suggesting androgen-mediated promotion of spermatogenesis must act via AR-expressing somatic cell-types. Several recent studies have exploited the Cre/lox system of conditional gene-targeting to ablate AR function from key somatic cell-types in order to establish the cell-specific role of AR in promotion of male fertility. In this study, we have used a similar approach to specifically ablate AR-signalling from Vascular Endothelial (VE) cells, with a view to defining the significance of androgen signalling within this cell-type on spermatogenesis.
AR expression in VE cells of the testicular vasculature was confirmed using an antibody against AR. A Cre-inducible fluorescent reporter line was used to empirically establish the utility of a mouse line expressing Cre Recombinase driven by the Tie2-Promoter, for targeting VE cells. Immunofluorescent detection revealed expression of YFP (and therefore Cre Recombinase function) limited to VE cells and an interstitial population of cells, believed to be macrophages, that did not express AR. Mating of Tie2-Cre males to females carrying a floxed AR gene produced Vascular Endothelial Androgen Receptor Knockout (VEARKO) mice and littermate controls. Ablation of AR from all VE cells was confirmed; however, no significant differences in bodyweight or reproductive tissue weights could be detected in VEARKO animals and spermatogenesis and fertility was unaffected.
We demonstrate the successful generation and empirical validation of a cell-specific knockout of AR from VE cells, and conclude that AR expression in VE cells is not essential for spermatogenesis or male fertility.
Androgens, produced by the testicular Leydig cells (LC), act as essential regulators of both the development of the male reproductive system and the initiation and maintenance of spermatogenesis in postnatal life (reviewed in [1, 2]). Androgens bind to the androgen receptor (AR), a member of the nuclear hormone receptor transcription factor superfamily, to modulate gene transcription in target cells . In the adult testis, Germ cells (GC), do not express AR, and GCs lacking a functional AR mature normally , consequently, androgens are believed to regulate spermatogenesis via androgen-AR signalling in AR-expressing testicular somatic cells. Recent exploitation of the Cre/lox system of conditional gene-targeting has elucidated the cell-specific role of AR in several key cell-types of the testis including Sertoli cells (SC) [5, 6], LCs , GCs , Peritubular myoid cells (PTM)  and vascular smooth muscle cells (VSM) .
A further cell-type expressing AR and consequently responsive to androgen signalling are the vascular endothelial (VE) cells . VE cells line the interior wall (Tunica Intima) of all vessels of the circulatory system. VE cells possess an anti-thrombotic surface which facilitates laminar blood flow, whilst permitting nutrients and macromolecules to flow out of the bloodstream through intercellular spaces, the result of endothelial cell contraction or active transport through the cells themselves by transcytosis. The endothelium also regulates angiogenesis, vasoregulation, and leucocyte trafficking into sites of injury during inflammatory responses (for review see ).
There remains some debate in the literature regarding the presence of AR within testicular VE cells, with studies arguing both for and against AR expression [13–15]. Given the wide-ranging impact of VE function on both the vascular system and peripheral organs, expression of AR within VE cells of the testicular blood vessels would raise the possibility that androgen-mediated modulation of endothelial cell function within the testis contributes to the regulation of spermatogenesis. To address this we first sought to unequivocally establish whether testicular VE cells express AR in vivo. We then exploited a conditional gene targeting approach to specifically ablate AR from endothelial cells of the vascular system to examine the impact of perturbed endothelial AR-signalling on spermatogenesis and male fertility.
Localisation of AR expression in the testicular vasculature
To confirm that vascular endothelial (VE) cells of the testicular vasculature express AR, immunofluorescent detection of AR was performed on sections of testis taken from control adult animals (n = 3). Nuclear AR expression was confirmed within all smooth muscle cells of the vasculature as previously described . In addition, AR localised to the nucleus of approximately fifty percent of testicular VE cells (Figure 1a).
Empirical validation of a VE-specific Cre Recombinase mouse line
In order to specifically target AR in VE cells, a mouse line carrying a Cre Recombinase transgene driven by the promoter of the endothelial-specific angiopoietin receptor Tie2 was exploited . To empirically establish the specificity of Cre Recombinase expression, (an essential requirement prior to any conditional gene-targeting experiment ), heterozygous Tie2-Cre males were mated to homozygous R26EYFPR females  and testes from offspring examined at adulthood. Expression of YFP was detected only in offspring inheriting the Tie2-Cre transgene (n = 3 per genotype). Within the testis of these animals, YFP expression was detected in VE cells of the blood vessel Tunica Intima (Figure 1b); however, a further population of interstitial cells also expressed YFP. Previous studies suggest these interstitial cells are likely to be macrophages which arise along with endothelial cells from a common Tie2-expressing progenitor population [19, 20]. Double immunofluorescent analysis on adult testis sections (n = 3) using antibodies directed against AR and YFP clearly demonstrated that a proportion of the YFP-positive VE cells were also AR-positive (Figure 1c) but that YFP-positive interstitial cells do not express AR (Figure 1d); we therefore concluded that, although we would be deleting AR in both populations, the Tie2-Cre line had utility for specific ablation of AR-function in the Vascular Endothelium. Furthermore, no significant difference in bodyweight or seminal vesicle weight could be detected and spermatogenesis was confirmed to be normal in Tie2-Cre:R26YFPR animals (data not shown), demonstrating that the presence of the Cre Recombinase transgene did not itself induce a phenotype.
Generation of VEARKO mice
To generate Vascular Endothelial Androgen Receptor Knock-Out (VEARKO) mice and littermate controls, heterozygous Tie2-Cre males were mated to homozygous ARflox  females. Offspring were genotyped by PCR to establish inheritance of the Tie2-Cre transgene (Figure 2a).
PCR interrogation of genomic DNA extracted from testes of VEARKO mice confirmed ablation of AR from a subset of testicular cells (Figure 2b). No ablation was detected in littermate control testes (n = 5 per genotype). Immunofluorescent detection of AR protein on testis sections from VEARKO animals confirmed that ablation of normal AR-signalling within the testis was limited to VE cells, with AR ablated from all VE cells examined (n = 3) (Figure 2d). AR expression was retained in control littermates (n = 3).
Phenotypic analysis of VEARKO mice
Comparison of bodyweight, seminal vesicle (SV) weight, and anogenital distance (a marker of androgen action during the masculinisation programming window ), revealed no significant difference between VEARKO males and controls (table 1) when examined in adulthood (postnatal day 57) (n = 3 per genotype); testes were fully descended into the scrotum.
Gross phenotypic analysis revealed no significant difference in testis weight between VEARKO mice and controls in adulthood (Figure 3a). Blind-scoring of testicular sections from VEARKO and control mice (n = 5 per genotype) identified no phenotypic differences in testicular architecture with all stages of spermatogenesis present (Figure 3b-e) and morphologically mature spermatozoa detected in the cauda epididymis (Figure 3f-g). To determine fertility status, seven VEARKO males and five littermate controls were each housed individually with a 129SV/C57BL/6 JF1 female for five days. No significant difference was observed either in mating success (production of pups), or in average litter size. All seven VEARKO males and four of five control males sired pups with an average litter size of 7.857 ± 0.3401 (n = 7) and 8.250 ± 0.4787 (n = 4) respectively.
The testicular vasculature is known to be an important regulator of both testis development [20, 22] and function . The vascular endothelium which lines every blood vessel of the circulatory system and controls nutrient, macromolecule and immune cell entry into peripheral tissues, acts as an important regulator of the testicular micro-environment, and is known to respond to sex steroid hormone stimulation (for reviews see [23–25]). We have demonstrated that VE cells of the testicular vascular system express AR in vivo and thus are responsive to androgen-stimulation. However, surprisingly, AR expression was limited to approximately fifty percent of VE cells. Whether this represents two different functional populations of VE cells, a 'snap-shot' of AR expression cycling in all VE cells, or a response by certain cells to a specific localised signal requires further investigation.
Empirical validation of Cre Recombinase expression in the Tie2-Cre line provides a good example of why such validation is necessary (reviewed in ). Whilst we predicted VE expression of Cre Recombinase, further expression in an interstitial population of cells was unexpected. Based upon previous characterisation of the Tie2-Cre line, these cells are likely to be macrophages [19, 20] which are known to physically localise in close proximity to AR-expressing Leydig Cells. Consequently the Tie2-Cre line is likely to have further utility as a testicular macrophage-targeting Cre Recombinase, this requires further empirical validation. For this study, however, the absence of detectable AR expression in these interstitial cells confirmed that the Tie2-Cre line had utility for ablating AR expression specifically from VE cells.
A combination of genomic PCR and immunofluorescent localisation confirmed specific AR ablation from the VE cells of the testis in VEARKO mice. However, unlike our previous study targeting AR in the smooth muscle cells of the testicular vasculature , we observed no significant difference in testis weight, seminal vesicle weight (a surrogate marker of circulating testosterone concentration), or any impact on spermatogenesis or fertility in VEARKO mice. We cannot rule out a role for VE-AR expression in aspects of testicular function other than support of spermatogenesis, however completion of spermatogenesis also requires production of androgens by normally functioning Leydig cells , and thus were there to be an impact on steroidogenesis, completion of spermatogenesis allows us to infer that this is also likely to be relatively minor. This requires further investigation. Nevertheless, this focused study unequivocally demonstrates successful generation of a mouse model lacking AR-signalling in VE cells of the circulatory system and confirms that AR-signalling via VE cells is not an essential requirement for spermatogenesis and male fertility.
Production of VEARKO and YFP reporter mice
Mice in which the AR has been selectively ablated from VE cells were generated using Cre/loxP technology. Male congenic C57BL/6 J carrying a random insertion of Tie2-Cre  were mated to C57BL/6 J female mice homozygous for a floxed AR . The +/Cre, ARflox/y male offspring from these matings were termed 'VEARKO', whereas the +/+, ARflox/y littermates were used as controls, termed 'control'. A Cre-inducible yellow fluorescent protein (YFP) reporter line used to document the expression of the Tie2-Cre transgene was generated by mating Tie-Cre males to female mice homozygous for a YFP transgene inserted into the Rosa26 locus . Sex and genotype ratios were all identified at the expected Mendelian ratios. The study was approved by The University of Edinburgh Ethics Committee and conducted under licensed approval from the UK Home Office (PPL: 60/3544).
Eight week old VEARKO male mice (n = 7) and littermate controls (n = 5) were singly housed with 129SV/C57BL/6 J females for a period of five days. Females were culled by inhalation of carbon dioxide and subsequent cervical dislocation, and fetuses counted ten days later.
Recovery of reproductive tissues
Male mice were culled at post-natal day (d) 57 by inhalation of carbon dioxide and subsequent cervical dislocation. Body weight and anogenital distance were measured and mice were examined for any gross abnormalities of the reproductive system. Testes and SV were removed and weighed. Tissues were fixed in Bouin's fixative (Clin-Tech, Guildford, UK) for 6 h. Bouin's-fixed tissues were processed and embedded in paraffin wax, and 5-μm sections were used for histological analysis as reported previously . Sections of testis were stained with hematoxylin and eosin using standard protocols and examined for histological abnormalities.
Single immunofluorescent staining for AR (Santa Cruz sc-816) was performed on VEARKO and littermate controls and double fluorescent staining for AR/YFP (Abcam ab38689) or YFP/CD31 (Abcam ab28364) was performed on YFP reporter mice. Sections were deparaffinized and rehydrated, and high-pressure antigen retrieval was performed in 0.01 M pH6 citrate buffer for 5 min. Endogenous peroxidase was blocked using 3% hydrogen peroxide in methanol and non-specific antibody binding sites were blocked with a mixture of 20% normal goat serum/80% tris-buffered saline/5% bovine serum albumin (NGS/TBS/BSA). Sections were incubated overnight at 4°C with the primary antibody diluted in NGS/TBS/BSA. Immunostaining was detected using the appropriate secondary antibody (Goat anti-rabbit peroxidase (Dako P0448), or Goat anti-mouse peroxidase (Dako P0447)) diluted 1:200 in NGS/TBS/BSA incubated for one hour at room temperature, then fluorescein Tyramide Signal Amplification system ('TSA™', Perkin Elmer) diluted 1:50 in its own buffer to manufacturers instructions for 10 min at room temperature. If a second primary antibody was used, the process was then repeated from the peroxidase block onwards with the appropriate conditions and detection for the second antibody and use of Cyanine - 5 TSA™ for a different fluorescent wavelength to distinguish between the two antibodies. Slides were counterstained with propidium iodide (Sigma, UK, #P4170) and mounted with PermaFluor mounting medium (Thermo Scientific, UK). Images were captured using a LSM 710 confocal microscope (Zeiss) with Zen software. A minimum of three mice of each genotype were used and sections from VEARKO and control littermates were processed in parallel on the same slide, on at least two separate occasions. Appropriate negative controls were included to ensure that any staining observed was specific.
PCR genotyping of mice
Mice were genotyped for inheritance of Cre Recombinase as previously described . PCR amplification products were resolved using a QiaXcel capillary system (Qiagen, UK). An amplicon of 324 bp acted as a positive internal control whilst an amplicon of 102 bp indicated inheritance of the Cre Recombinase transgene.
Determination of genomic ablation of AR
DNA was isolated from a piece of frozen testis using a Mouse tail genomic DNA kit (Gen-Probe Life Sciences Ltd, UK) according to the manufacturer's instructions and subjected to PCR amplification using primers GCTGATCATAGGCCTCTCTC and TGCCCTGAAAGCAGTCCTCT and Biomix Red Taq polymerase PCR kit (Bioline, UK). PCR amplification products were resolved using a QiaXcel capillary system (Qiagen, UK). An amplicon of 1142 bp indicated presence of a floxed AR whilst an amplicon of 612 bp indicated recombination between loxP sites and deletion of AR exon 2.
Statistical analyses of weights, AGD and fertility testing were carried out in GraphPad Prism (version 5; GraphPad Software Inc., San Diego, CA, USA) using a 2-tailed unpaired t test.
McLachlan RI, O'Donnell L, Meacham SJ, Stanton PG, de Krester DM, Pratis K, Robertson DM: Recent Progress in Hormome Research. 2002, 57: 149-179. 10.1210/rp.57.1.149.
Sharpe RM: The Physiology of Reproduction. Edited by: Knobil EaN. 1994, J.D. New York: Raven, 1363-2434.
Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS: Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev. 1995, 16: 271-321.
Johnston DS, Russell LD, Friel PJ, Griswold MD: Murine germ cells do not require functional androgen receptors to complete spermatogenesis following spermatogonial stem cell transplantation. Endocrinology. 2001, 142: 2405-2408. 10.1210/en.142.6.2405.
De Gendt K, Swinnen JV, Saunders PT, Schoonjans L, Dewerchin M, Devos A, Tan K, Atanassova N, Claessens F, Lecureuil C, et al: A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis. Proc Natl Acad Sci USA. 2004, 101: 1327-1332. 10.1073/pnas.0308114100.
Chang C, Chen YT, Yeh SD, Xu Q, Wang RS, Guillou F, Lardy H, Yeh S: Infertility with defective spermatogenesis and hypotestosteronemia in male mice lacking the androgen receptor in Sertoli cells. Proc Natl Acad Sci USA. 2004, 101: 6876-6881. 10.1073/pnas.0307306101.
Xu Q, Lin HY, Yeh SD, Yu IC, Wang RS, Chen YT, Zhang C, Altuwaijri S, Chen LM, Chuang KH, et al: Infertility with defective spermatogenesis and steroidogenesis in male mice lacking androgen receptor in Leydig cells. Endocrine. 2007, 32: 96-106. 10.1007/s12020-007-9015-0.
Tsai MY, Yeh SD, Wang RS, Yeh S, Zhang C, Lin HY, Tzeng CR, Chang C: Differential effects of spermatogenesis and fertility in mice lacking androgen receptor in individual testis cells. Proc Natl Acad Sci USA. 2006, 103: 18975-18980. 10.1073/pnas.0608565103.
Welsh M, Saunders PT, Atanassova N, Sharpe RM, Smith LB: Androgen action via testicular peritubular myoid cells is essential for male fertility. Faseb J. 2009, 23: 4218-4230. 10.1096/fj.09-138347.
Welsh M, Sharpe RM, Moffat L, Atanassova N, Saunders PT, Kilter S, Bergh A, Smith LB: Androgen action via testicular arteriole smooth muscle cells is important for Leydig cell function, vasomotion and testicular fluid dynamics. PLoS One. 2010, 5: e13632-10.1371/journal.pone.0013632.
Liu PY, Death AK, Handelsman DJ: Androgens and cardiovascular disease. Endocr Rev. 2003, 24: 313-340. 10.1210/er.2003-0005.
Limaye V, Vadas M: The vascular endothelium: structure and function. Mechanisms of Vascular DIsease. Edited by: Fitridge R, Thompson M. 2007, Cambridge: Canmbridge University Press, 1-10.
Nakhla AM, Mather JP, Janne OA, Bardin CW: Estrogen and androgen receptors in Sertoli, Leydig, myoid, and epithelial cells: effects of time in culture and cell density. Endocrinology. 1984, 115: 121-128. 10.1210/endo-115-1-121.
Pelletier G, Labrie C, Labrie F: Localization of oestrogen receptor alpha, oestrogen receptor beta and androgen receptors in the rat reproductive organs. J Endocrinol. 2000, 165: 359-370. 10.1677/joe.0.1650359.
Vornberger W, Prins G, Musto NA, Suarez-Quian CA: Androgen receptor distribution in rat testis: new implications for androgen regulation of spermatogenesis. Endocrinology. 1994, 134: 2307-2316. 10.1210/en.134.5.2307.
Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M: Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol. 2001, 230: 230-242. 10.1006/dbio.2000.0106.
Smith L: Good planning and serendipity: exploiting the Cre/Lox system in the testis. Reproduction. 2011, 141: 151-161. 10.1530/REP-10-0404.
Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM, Costantini F: Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol. 2001, 1: 4-10.1186/1471-213X-1-4.
Bailey AS, Willenbring H, Jiang S, Anderson DA, Schroeder DA, Wong MH, Grompe M, Fleming WH: Myeloid lineage progenitors give rise to vascular endothelium. Proc Natl Acad Sci USA. 2006, 103: 13156-13161. 10.1073/pnas.0604203103.
Coveney D, Cool J, Oliver T, Capel B: Four-dimensional analysis of vascularization during primary development of an organ, the gonad. Proc Natl Acad Sci USA. 2008, 105: 7212-7217. 10.1073/pnas.0707674105.
Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, Smith LB, Sharpe RM: Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest. 2008, 118: 1479-1490. 10.1172/JCI34241.
Cool J, DeFalco TJ, Capel B: Vascular-mesenchymal cross-talk through Vegf and Pdgf drives organ patterning. Proc Natl Acad Sci USA. 2011, 108: 167-172. 10.1073/pnas.1010299108.
Arnal JF, Fontaine C, Billon-Gales A, Favre J, Laurell H, Lenfant F, Gourdy P: Estrogen receptors and endothelium. Arterioscler Thromb Vasc Biol. 2010, 30: 1506-1512. 10.1161/ATVBAHA.109.191221.
Chow RW, Handelsman DJ, Ng MK: Minireview: rapid actions of sex steroids in the endothelium. Endocrinology. 2010, 151: 2411-2422. 10.1210/en.2009-1456.
Miller VM, Mulvagh SL: Sex steroids and endothelial function: translating basic science to clinical practice. Trends Pharmacol Sci. 2007, 28: 263-270. 10.1016/j.tips.2007.04.004.
Sharpe RM, Maddocks S, Kerr JB: Cell-cell interactions in the control of spermatogenesis as studied using Leydig cell destruction and testosterone replacement. Am J Anat. 1990, 188: 3-20. 10.1002/aja.1001880103.
We are grateful to Karel De Gendt and Guido Verhoeven (Katholic University of Leuven, Leuven, Belgium) for provision of the ARflox mice and Yuri Kotelevtsev (BHF Centre for Cardiovascular Sciences, University of Edinburgh) for provision of the Tie2-Cre mice. We also thank Mark Fisken, Lindsey Moffat, Nancy Nelson and the members of the MRC Centre for Reproductive Health histology department for technical assistance.
The authors declare that they have no competing interests.
LBS conceived the study; LO carried out the experiments; LO and LBS wrote the paper. All authors read and approved the final manuscript.